West Pharmaceutical Services, Inc. (NYSE:WST) Shares Acquired by IFM Investors Pty Ltd
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Acquired by IFM Investors Pty Ltd
IFM Investors Pty Ltd increased its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating) by 14.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,788 shares of the medical instruments supplier's stock after buying an additional 1,654 shares during the quarter. IFM Investors Pty Ltd's holdings in West Pharmaceutical Services were worth $3,867,000 as of its most recent filing with the Securities and Exchange Commission.
IFM Investors Pty Ltd根据其最近提交给美国证券交易委员会的Form 13F文件，在第二季度增持了West Pharmtics Services，Inc.(纽约证券交易所代码：WST-GET评级)的股票14.9%。该公司在本季度额外购买了1,654股后，持有这家医疗器械供应商的12,788股股票。截至最近提交给美国证券交易委员会的文件，IFM Investors Pty Ltd在West Pharmtics Services持有的股份价值386.7万美元。
Several other large investors have also recently added to or reduced their stakes in WST. BlackRock Inc. lifted its position in West Pharmaceutical Services by 8.9% during the fourth quarter. BlackRock Inc. now owns 8,094,288 shares of the medical instruments supplier's stock worth $3,796,302,000 after buying an additional 664,275 shares during the period. Norges Bank purchased a new position in shares of West Pharmaceutical Services in the 4th quarter worth about $307,506,000. Bank of America Corp DE raised its holdings in shares of West Pharmaceutical Services by 36.7% in the 1st quarter. Bank of America Corp DE now owns 639,632 shares of the medical instruments supplier's stock worth $262,703,000 after purchasing an additional 171,554 shares during the period. Fiera Capital Corp raised its holdings in shares of West Pharmaceutical Services by 3,441.3% in the 1st quarter. Fiera Capital Corp now owns 86,762 shares of the medical instruments supplier's stock worth $35,634,000 after purchasing an additional 84,312 shares during the period. Finally, Vanguard Group Inc. raised its holdings in shares of West Pharmaceutical Services by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 8,716,312 shares of the medical instruments supplier's stock worth $3,579,876,000 after purchasing an additional 82,459 shares during the period. 91.98% of the stock is currently owned by hedge funds and other institutional investors.
其他几家大型投资者最近也增持或减持了WST的股份。第四季度，贝莱德股份有限公司将其在西部医药服务公司的持股比例提高了8.9%。贝莱德股份有限公司在此期间增持了664,275股，目前持有这家医疗器械供应商8,094,288股股票，价值3,796,302,000美元。挪威银行在第四季度购买了西方制药服务公司的新头寸，价值约307,506,000美元。第一季度，美国银行(Bank Of America Corp DE)将其持有的西方制药服务公司的股票增加了36.7%。美国银行DE目前持有639,632股这家医疗器械供应商的股票，价值262,703,000美元，在此期间又购买了171,554股。Fiera Capital Corp在第一季度增持了3,441.3%的西方制药服务公司的股票。Fiera Capital Corp目前持有这家医疗器械供应商的86,762股股票，价值35,634,000美元，在此期间又购买了84,312股。最后，先锋集团(Vanguard Group Inc.)在第一季度增持了西部医药服务公司的股票1.0%。先锋集团现在持有这家医疗器械供应商的8,716,312股股票，价值3,579,876,000美元，在此期间又购买了82,459股。91.98%的股票目前由对冲基金和其他机构投资者持有。
West Pharmaceutical Services Stock Performance
西部医药服务公司股票表现
West Pharmaceutical Services stock opened at $254.24 on Friday. The stock's 50-day moving average is $309.28 and its 200-day moving average is $327.42. The company has a market cap of $18.83 billion, a price-to-earnings ratio of 28.22, a price-to-earnings-growth ratio of 1.03 and a beta of 1.18. The company has a debt-to-equity ratio of 0.09, a current ratio of 3.13 and a quick ratio of 2.41. West Pharmaceutical Services, Inc. has a 12 month low of $248.95 and a 12 month high of $475.00.
西部制药服务公司的股票周五开盘报254.24美元。该股的50日移动均线切入位在309.28美元，200日移动均线切入位在327.42美元。该公司市值为188.3亿美元，市盈率为28.22倍，市盈率为1.03倍，贝塔系数为1.18。该公司的债务权益比为0.09，流动比率为3.13，速动比率为2.41。West Pharmtics Services，Inc.的12个月低点为248.95美元，12个月高位为475.00美元。
Insider Transactions at West Pharmaceutical Services
西方医药服务公司的内幕交易
In related news, insider Silji Abraham sold 5,374 shares of the firm's stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $343.93, for a total transaction of $1,848,279.82. Following the sale, the insider now directly owns 3,201 shares in the company, valued at approximately $1,100,919.93. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 0.60% of the company's stock.
在相关新闻中，内部人士Silji Abraham在8月1日星期一的一笔交易中出售了5374股该公司的股票。股票以343.93美元的平均价格出售，总成交金额为1,848,279.82美元。出售后，这位内部人士现在直接拥有该公司3,201股，价值约1,100,919.93美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的，该文件可通过这个环节。公司内部人士持有该公司0.60%的股份。
West Pharmaceutical Services Company Profile
西部医药服务公司简介
(Get Rating)
(获取评级)
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
西方制药服务公司在美洲、欧洲、中东、非洲和亚太地区设计、制造和销售可注射药物和保健产品的容器和输送系统。它分为两个部分，专有产品和合同制造产品。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on West Pharmaceutical Services (WST)
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- 2 Semiconductor Stocks To Watch For Reversals
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- 免费获取StockNews.com关于West Pharmtics Services(WST)的研究报告
- 华尔街对Datadog的热情会带来巨大的收益吗？
- MarketBeat：回顾一周9/19-9/23
- 为什么特斯拉的股票保持弹性？
- 需要关注的2只半导体类股走势逆转
- 好市多盈利后价格疲软是买入的好时机吗？
Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating).
想看看还有哪些对冲基金持有WST吗？访问HoldingsChannel.com获取西方制药服务公司(纽约证券交易所代码：WST-GET Rating)的最新13F文件和内幕交易。
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.
接受《西部医药服务报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对West Pharmtics Services和相关公司的最新新闻和分析师评级的每日简要摘要。